Market Overview

Star Scientific Announces Successful First Look at the "Flint" CRP Human Study and Provides Updated Report on ASAP Human Thyroid Study

Share:
Related
Mid-Afternoon Market Update: Markets Continue to Rally as InfoBlox Takes a Big Haircut
Mid-Day Market Update: Dow Rises Over 1%; Cadence Pharma Shares Gain On Acquisition News

Star Scientific, Inc. (NASDAQ: STSI), announced today that the Roskamp Institute has reported positive findings in its analysis of 100 subjects who completed the "Flint" CRP study that analyzes the effects of dietary supplementation with Anatabloc® in humans.  The Company is also reporting additional information relating to its ASAP human thyroid study.  

Posted-In: News FDA

 

Related Articles (STSI)

View Comments and Join the Discussion!